Vaccine for the masses
Serum Institute of India Ltd broke its reticence early this month to announce a 40 per cent slashing of the price of its hepatitis-B vaccine, Gene Vac-B. The price cut, according to S.S. Jadhav,
Related Content
- Somalia economic update: investing in health to anchor growth
- 2018 assessment report of the global vaccine action plan
- Mass measles vaccination under way in Western Cape as nine cases confirmed
- Anti-measles campaign in five Yangon townships
- Mathematical modeling of programmatic requirements for Yaws eradication
- Government lie on Japanese Encephalitis exposed